GMO International Quality ETF (QLTI)
What the fund holds and why
QLTI is an actively managed fund, meaning human stock-pickers at GMO do the selecting rather than a passive index. The fund aims to own the highest-quality businesses outside the United States among the world’s developed economies — principally Europe, Japan, Canada, and Australia. The holdings are typically large-cap or mid-cap companies with strong market positions, profitable operations, and clean balance sheets.
Quality is a loaded word in investing, but GMO’s framework is concrete. They screen for companies with high returns on capital, stable and growing profitability, reasonable debt levels, and the sort of competitive advantages that allow them to sustain those returns. A pharmaceutical company with a portfolio of blockbuster drugs, a bank with a loyal customer base and cost discipline, a machinery manufacturer known for reliability and durability — these are the kinds of businesses the fund pursues. The opposite of quality, in this framework, is a business with deteriorating margins, rising debt, or competitive advantage that is eroding.
Because it is actively managed, the fund can own anywhere from 50 to 80 stocks. It is not trying to own every developed-market company outside the US; it is trying to own the best ones. That means it does not hold an index-like weight in every country or every sector. It may be overweight Japan and underweight the UK, depending on where the fund’s managers find quality at attractive valuations.
The concentration and diversification trade-off
An actively managed fund is leaner than a passive index fund, which must hold hundreds or thousands of names to track an index. That leanness can be an advantage or a drawback. On one hand, if the stock-pickers are right, their conviction — the fact that they hold 50 names instead of 500 — can amplify the payoff. On the other hand, there is more key-person risk. The fund’s performance depends on whether the decision-makers at GMO can consistently identify quality better than the market can. That is a high bar.
QLTI’s geographic diversification is real — it holds stocks across multiple continents and in multiple currencies, which provides some insulation from the risk that any single country’s economy or stock market will stumble. But because the fund holds only 50–80 names, its top ten holdings typically represent about 30% to 40% of the portfolio. Concentrated enough that a few bad picks can hurt, but not so concentrated that a single stock can derail the entire fund.
The underlying currency and economic risks
Because QLTI holds non-US stocks, it is exposed to currency movements. A stock in euros or yen or sterling will fluctuate in US-dollar terms both because of the stock’s own price and because of the exchange rate. A euro that strengthens against the dollar can boost QLTI’s value, even if the underlying European stocks trade flat. Conversely, a strong dollar can be a headwind. QLTI does not hedge currency exposure — it holds currencies as they come. An investor concerned about currency volatility should know this is a feature of the fund, not a bug to be fixed; managing currency exposure is part of the active management.
Economically, the fund is diversified across developed economies with different cyclical positions and growth profiles. Japan is mature and slow-growing but stable. Europe has heterogeneous growth rates — Germany and France are different beasts. Canada and Australia are commodity-exposed and cyclical. That mix provides some ballast if one region stumbles.
Quality versus value and the fee structure
Quality stocks — companies with high margins, strong competitive positions, and predictable profits — often trade at premium valuations relative to the broader market. They are expensive. This means that if the market becomes cheap on value stocks and expensive on quality stocks, QLTI could underperform a value-focused fund. Conversely, if investors flock to quality, QLTI can outperform. Over long periods, the fund’s track record will depend on whether the quality premium persists and whether GMO’s stock-picking adds value beyond the inherent quality tilt.
The expense ratio of 0.59% is higher than a passive index fund (which might cost 0.05% to 0.20%) but not onerous for an actively managed strategy. You are paying for active management, and that fee should be justified by outperformance. A fair question for any investor is: has QLTI beaten the equivalent passive index by more than 0.59% annually after fees? That check is the most important one to run.
How to evaluate this fund
Research QLTI by reading GMO’s strategy documents, which explain the quality framework and the approach to stock selection. Compare the fund’s returns versus a passive developed-market ex-US index fund over a period of at least three to five years. Active management’s value only becomes clear over cycles. In a single year, luck can dominate. Also check the fund’s turnover — how often holdings change. High turnover can incur tax drag and suggest the managers are chasing trends rather than holding high-conviction positions. Examine the top holdings to get a feel for what “quality” actually looks like in GMO’s hands. A fund that holds mainly defensive multinationals is taking a different bet than one tilted toward profitable tech companies or emerging industrial champions.